nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—PTGIS—Nicotinamide salvaging—PTGS2—adrenal gland cancer	0.0794	0.0794	CbGpPWpGaD
Epoprostenol—PTGIS—Nicotinate metabolism—PTGS2—adrenal gland cancer	0.0422	0.0422	CbGpPWpGaD
Epoprostenol—PTGIR—Prostacyclin signalling through prostacyclin receptor—GNAS—adrenal gland cancer	0.0372	0.0372	CbGpPWpGaD
Epoprostenol—PTGIS—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—adrenal gland cancer	0.0348	0.0348	CbGpPWpGaD
Epoprostenol—PTGIS—Endogenous sterols—POMC—adrenal gland cancer	0.0294	0.0294	CbGpPWpGaD
Epoprostenol—PTGIR—Endothelin Pathways—GNAS—adrenal gland cancer	0.0239	0.0239	CbGpPWpGaD
Epoprostenol—PTGIS—Eicosanoid Synthesis—PTGS2—adrenal gland cancer	0.0226	0.0226	CbGpPWpGaD
Epoprostenol—PTGIR—Thromboxane A2 receptor signaling—PRKACA—adrenal gland cancer	0.0193	0.0193	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0192	0.0192	CbGpPWpGaD
Epoprostenol—PTGIS—Prostaglandin Synthesis and Regulation—PTGS2—adrenal gland cancer	0.0189	0.0189	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0172	0.0172	CbGpPWpGaD
Epoprostenol—PTGIR—G alpha (s) signalling events—TSHR—adrenal gland cancer	0.0143	0.0143	CbGpPWpGaD
Epoprostenol—PTGIR—Prostaglandin Synthesis and Regulation—PTGS2—adrenal gland cancer	0.0139	0.0139	CbGpPWpGaD
Epoprostenol—PTGER1—Prostaglandin Synthesis and Regulation—PTGS2—adrenal gland cancer	0.0139	0.0139	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0138	0.0138	CbGpPWpGaD
Epoprostenol—PTGIS—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.0136	0.0136	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0127	0.0127	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0127	0.0127	CbGpPWpGaD
Epoprostenol—PTGIS—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.0126	0.0126	CbGpPWpGaD
Epoprostenol—PTGIR—Platelet homeostasis—GNAS—adrenal gland cancer	0.012	0.012	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.0115	0.0115	CbGpPWpGaD
Epoprostenol—PTGIS—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.0111	0.0111	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0105	0.0105	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.0103	0.0103	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00969	0.00969	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00969	0.00969	CbGpPWpGaD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.00829	0.00829	CbGpPWpGaD
Epoprostenol—PTGIR—G alpha (s) signalling events—GNAS—adrenal gland cancer	0.00829	0.00829	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00828	0.00828	CbGpPWpGaD
Epoprostenol—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—adrenal gland cancer	0.00808	0.00808	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00762	0.00762	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00762	0.00762	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00738	0.00738	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—RB1—adrenal gland cancer	0.00713	0.00713	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00679	0.00679	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00679	0.00679	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00631	0.00631	CbGpPWpGaD
Epoprostenol—PTGIR—Thromboxane A2 receptor signaling—EGFR—adrenal gland cancer	0.00596	0.00596	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00595	0.00595	CbGpPWpGaD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.00594	0.00594	CbGpPWpGaD
Epoprostenol—PTGIS—Biological oxidations—POMC—adrenal gland cancer	0.00587	0.00587	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00581	0.00581	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00581	0.00581	CbGpPWpGaD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.00572	0.00572	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00566	0.00566	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—TSHR—adrenal gland cancer	0.00562	0.00562	CbGpPWpGaD
Epoprostenol—PTGIR—G alpha (s) signalling events—POMC—adrenal gland cancer	0.00558	0.00558	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00548	0.00548	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00548	0.00548	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0054	0.0054	CbGpPWpGaD
Epoprostenol—P2RY12—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.0054	0.0054	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—SH3KBP1—adrenal gland cancer	0.00533	0.00533	CbGpPWpGaD
Epoprostenol—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00531	0.00531	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—SDHB—adrenal gland cancer	0.00525	0.00525	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—CTNNB1—adrenal gland cancer	0.00524	0.00524	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—TSHR—adrenal gland cancer	0.00517	0.00517	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00517	0.00517	CbGpPWpGaD
Epoprostenol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00506	0.00506	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—ZNRF3—adrenal gland cancer	0.00501	0.00501	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00497	0.00497	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00497	0.00497	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—SPARC—adrenal gland cancer	0.00427	0.00427	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00413	0.00413	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—SPARC—adrenal gland cancer	0.00393	0.00393	CbGpPWpGaD
Epoprostenol—P2RY12—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00364	0.00364	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—PRKACA—adrenal gland cancer	0.00361	0.00361	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00356	0.00356	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—RRM1—adrenal gland cancer	0.00338	0.00338	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—SDHD—adrenal gland cancer	0.00338	0.00338	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—PRKACA—adrenal gland cancer	0.00332	0.00332	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00328	0.00328	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00328	0.00328	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—GNAS—adrenal gland cancer	0.00327	0.00327	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00324	0.00324	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—GNRHR—adrenal gland cancer	0.00319	0.00319	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00318	0.00318	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—SPRY2—adrenal gland cancer	0.00314	0.00314	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—CDC42—adrenal gland cancer	0.00306	0.00306	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00301	0.00301	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—GNAS—adrenal gland cancer	0.00301	0.00301	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00298	0.00298	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00298	0.00298	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00297	0.00297	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—IGF2—adrenal gland cancer	0.00295	0.00295	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—GNRHR—adrenal gland cancer	0.00294	0.00294	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00294	0.00294	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—GNAS—adrenal gland cancer	0.00292	0.00292	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00292	0.00292	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00292	0.00292	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00289	0.00289	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—TSHR—adrenal gland cancer	0.00289	0.00289	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—MEN1—adrenal gland cancer	0.00288	0.00288	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—CDC42—adrenal gland cancer	0.00282	0.00282	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00279	0.00279	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00273	0.00273	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00273	0.00273	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—IGF2—adrenal gland cancer	0.00271	0.00271	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—GNAS—adrenal gland cancer	0.00269	0.00269	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00266	0.00266	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00266	0.00266	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—TSHR—adrenal gland cancer	0.00266	0.00266	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00266	0.00266	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00257	0.00257	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00257	0.00257	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—MED12—adrenal gland cancer	0.00252	0.00252	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00225	0.00225	CbGpPWpGaD
Epoprostenol—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.0022	0.0022	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—POMC—adrenal gland cancer	0.0022	0.0022	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PRKACA—adrenal gland cancer	0.0022	0.0022	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00207	0.00207	CbGpPWpGaD
Epoprostenol—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00203	0.00203	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00203	0.00203	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—POMC—adrenal gland cancer	0.00203	0.00203	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—POMC—adrenal gland cancer	0.00203	0.00203	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00193	0.00193	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—GNRH1—adrenal gland cancer	0.00191	0.00191	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00191	0.00191	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00191	0.00191	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CDC42—adrenal gland cancer	0.00186	0.00186	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00185	0.00185	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PRKACA—adrenal gland cancer	0.00184	0.00184	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.0018	0.0018	CbGpPWpGaD
Epoprostenol—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00179	0.00179	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00178	0.00178	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00178	0.00178	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—GNRH1—adrenal gland cancer	0.00176	0.00176	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00176	0.00176	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CDC42—adrenal gland cancer	0.00176	0.00176	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SPRY2—adrenal gland cancer	0.00175	0.00175	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TSHR—adrenal gland cancer	0.0017	0.0017	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0017	0.0017	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0017	0.0017	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—GNAS—adrenal gland cancer	0.00168	0.00168	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00162	0.00162	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CDC42—adrenal gland cancer	0.00162	0.00162	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SPRY2—adrenal gland cancer	0.00161	0.00161	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00161	0.00161	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MEN1—adrenal gland cancer	0.0016	0.0016	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TSHR—adrenal gland cancer	0.00157	0.00157	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TSHR—adrenal gland cancer	0.00157	0.00157	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00154	0.00154	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—GNAS—adrenal gland cancer	0.00154	0.00154	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—TERT—adrenal gland cancer	0.00149	0.00149	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—GNAS—adrenal gland cancer	0.00149	0.00149	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MEN1—adrenal gland cancer	0.00147	0.00147	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MEN1—adrenal gland cancer	0.00147	0.00147	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—ABCB1—adrenal gland cancer	0.00146	0.00146	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—BAD—adrenal gland cancer	0.0013	0.0013	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—POMC—adrenal gland cancer	0.00124	0.00124	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PRKACA—adrenal gland cancer	0.00122	0.00122	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—BRAF—adrenal gland cancer	0.00118	0.00118	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—POMC—adrenal gland cancer	0.00115	0.00115	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—POMC—adrenal gland cancer	0.00115	0.00115	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—POMC—adrenal gland cancer	0.00113	0.00113	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PRKACA—adrenal gland cancer	0.00113	0.00113	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PRKACA—adrenal gland cancer	0.00113	0.00113	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—POMC—adrenal gland cancer	0.00104	0.00104	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—POMC—adrenal gland cancer	0.00104	0.00104	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CDC42—adrenal gland cancer	0.00104	0.00104	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—POMC—adrenal gland cancer	0.001	0.001	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IGF2—adrenal gland cancer	0.001	0.001	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—GNAS—adrenal gland cancer	0.000991	0.000991	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IGF1R—adrenal gland cancer	0.000967	0.000967	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PTGS2—adrenal gland cancer	0.000956	0.000956	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CDC42—adrenal gland cancer	0.000955	0.000955	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CDC42—adrenal gland cancer	0.000955	0.000955	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.000948	0.000948	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—TP53—adrenal gland cancer	0.000935	0.000935	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IGF2—adrenal gland cancer	0.00092	0.00092	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IGF2—adrenal gland cancer	0.00092	0.00092	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000915	0.000915	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—GNAS—adrenal gland cancer	0.000912	0.000912	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—GNAS—adrenal gland cancer	0.000912	0.000912	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IGF1R—adrenal gland cancer	0.00089	0.00089	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IGF1R—adrenal gland cancer	0.00089	0.00089	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—TP53—adrenal gland cancer	0.00086	0.00086	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CTNNB1—adrenal gland cancer	0.000855	0.000855	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.000848	0.000848	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TERT—adrenal gland cancer	0.000832	0.000832	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PTGS2—adrenal gland cancer	0.000801	0.000801	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TERT—adrenal gland cancer	0.000766	0.000766	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TERT—adrenal gland cancer	0.000766	0.000766	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—BAD—adrenal gland cancer	0.000724	0.000724	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—EGFR—adrenal gland cancer	0.000678	0.000678	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—POMC—adrenal gland cancer	0.000668	0.000668	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000667	0.000667	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—BAD—adrenal gland cancer	0.000666	0.000666	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—BAD—adrenal gland cancer	0.000666	0.000666	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—BRAF—adrenal gland cancer	0.000659	0.000659	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—EGFR—adrenal gland cancer	0.000639	0.000639	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—POMC—adrenal gland cancer	0.000614	0.000614	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—POMC—adrenal gland cancer	0.000614	0.000614	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—BRAF—adrenal gland cancer	0.000607	0.000607	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—BRAF—adrenal gland cancer	0.000607	0.000607	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—EGFR—adrenal gland cancer	0.000588	0.000588	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000588	0.000588	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.000546	0.000546	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.000546	0.000546	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000476	0.000476	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000438	0.000438	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000438	0.000438	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—MED12—adrenal gland cancer	0.000407	0.000407	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—EGFR—adrenal gland cancer	0.000377	0.000377	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000364	0.000364	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—EGFR—adrenal gland cancer	0.000347	0.000347	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—EGFR—adrenal gland cancer	0.000347	0.000347	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TP53—adrenal gland cancer	0.000317	0.000317	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	0.000297	0.000297	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TP53—adrenal gland cancer	0.000292	0.000292	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TP53—adrenal gland cancer	0.000292	0.000292	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000291	0.000291	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GNAS—adrenal gland cancer	0.000241	0.000241	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	0.000236	0.000236	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—POMC—adrenal gland cancer	0.000162	0.000162	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	0.000129	0.000129	CbGpPWpGaD
